Device Sectors
Pharmasset to Present at the UBS Global Life Sciences Conference
September 17, 2010 4:33 am | by Bio-Medicine.Org | News | CommentsPRINCETON, N.J., Sept 17 /- Pharmasset, Inc. (Nasdaq: VRUS ) announces that management will present at the UBS Global Life Sciences Conference to be held September 20-22, 2010 at the Grand Hyatt, New York, NY. Schaefer Price, Pharmasset's President and Chief Executive Officer, will...
Henry Schein to Present at the UBS Global Life Sciences Conference
September 17, 2010 4:32 am | by Bio-Medicine.Org | News | CommentsMELVILLE, N.Y., Sept. 17 /- Henry Schein, Inc., (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that Steven Paladino, Henry Schein's Executive Vice President and Chief Financial Officer, will present at the UBS...
Nottingham University Hospitals NHS Trust implements new integration engine
September 17, 2010 4:32 am | by RealWire | News | CommentsMoves from SeeBeyond to Java CAPSLondon, 17 September, 2010 - Nottingham University Hospitals NHS Trust (NUH) has chosen and implemented a new integration engine in order to create a more stable and robust environment for the huge number of interfaces between clinical and administrative...
Alere to Attend the Fifth Annual JMP Securities Healthcare Conference on September 28, 2010
September 17, 2010 12:32 am | by Bio-Medicine.Org | News | CommentsWALTHAM, Mass., Sept. 16 /- Alere Inc. (NYSE: ALR ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the Fifth Annual JMP Securities Healthcare Conference...
FDA expands approval of implants for heart failure
September 16, 2010 2:45 pm | by The Associated Press | News | CommentsThe Food and Drug Administration said Thursday it approved three implantable heart devices from Boston Scientific Corp. for a new use in treating heart failure patients.All three devices are cardiac resynchronization therapy defibrillators. The devices are implanted in the upper chest and use...
Baylor researchers advancing genetic treatment for ovarian cancer
September 16, 2010 1:35 pm | by Baylor College of Medicine | News | CommentsAs the understanding of the biology of ovarian cancer broadens, there is an increased need to develop treatments that are targeted toward a person's genetic makeup, said a clinician-researcher from Baylor College of Medicine. "We have not been able to pinpoint exactly what causes ovarian...
Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds
September 16, 2010 1:35 pm | by Boston Scientific | News | CommentsFDA approval is based on results from the Company's landmark MADIT-CRT trial
Reportlinker Adds Canadian Dental Market Overview & Dentist Survey 2010 (Implants, Prosthetics, Imaging & CAD/CAM)
September 16, 2010 11:32 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 16 /- Reportlinker.com announces that a new market research report is available in its catalogue: Canadian Dental Market Overview & Dentist Survey 2010 (Implants, Prosthetics, Imaging & CAD/CAM)...
Cynosure to Present at UBS Global Life Sciences Conference
September 16, 2010 10:33 am | by Bio-Medicine.Org | News | CommentsWESTFORD, Mass., Sept. 16 /- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 21. The...
Reportlinker Adds Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
September 16, 2010 10:33 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 16 /- Reportlinker.com announces that a new market research report is available in its catalogue: Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...
Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010
September 16, 2010 10:32 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 16 /- Reportlinker.com announces that a new market research report is available in its catalogue: U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010...
Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
September 16, 2010 10:32 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 16 /- Reportlinker.com announces that a new market research report is available in its catalogue: Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...
LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results
September 16, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsORLANDO, Fla., Sept. 16 /- LightPath Technologies, Inc. (Nasdaq: LPTH ) (the "Company", "LightPath", or "we"), a global manufacturer, distributor and integrator of patented optical components and high-level assemblies, announced today its financial results for the fourth quarter and...
Olympus Launches 2011 National Innovation Awards Program
September 16, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsCENTER VALLEY, Pa., Sept. 16 /- Olympus, a precision technology leader designing and delivering innovative solutions in its core business areas of Medical and Surgical Products, Life Science Imaging Systems, Industrial Measurement and Imaging Instruments and Cameras and Audio Products,...
Fact or Fiction: ADHD in America, a Capitol Hill Forum
September 16, 2010 9:35 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, Sept. 16 /- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, has partnered with the Entertainment Industries Council (EIC) , the Lab School of Washington and other organizations in support of National Attention Deficit Hyperactivity...
Imbalanced diet and inadequate exercise may underlie asthma in children
September 16, 2010 9:34 am | by EurekAlert | News | Comments(American Thoracic Society) Even children of a healthy weight who have an imbalanced metabolism due to poor diet or exercise may be at increased risk of asthma, according to new research, which challenges the widespread assumption that obesity itself is a risk factor for asthma.
Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research
September 16, 2010 9:33 am | by Bio-Medicine.Org | News | CommentsHOUSTON, Sept. 16 /- Ascendant Neuro is pleased to announce the addition of Kenneth Alo, M.D., an internationally recognized specialist who has joined to further the advancement of the group's minimally invasive pain treatment techniques through the innovative use of neurostimulators ....
Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference
September 16, 2010 9:33 am | by Bio-Medicine.Org | News | CommentsFRANKLIN, Mass., Sept. 16 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug...
Roche Diagnostics Introduces Full Line of 9-Minute STAT Assays for Cardiac Biomarker Testing on cobas 6000 Analyzer Series
September 16, 2010 7:31 am | by Bio-Medicine.Org | News | CommentsINDIANAPOLIS, Sept. 16 /- Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has introduced a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas ® 6000 analyzer series, an integrated system designed for diagnostic labs with medium...
CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010
September 16, 2010 7:31 am | by Bio-Medicine.Org | News | CommentsWASHINGTON, Sept. 16 /- CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday,...
MarketsandMarkets: Global Minimally Invasive Surgery (MIS) Market Worth US$ 90.4 Billion by 2015.
September 16, 2010 5:33 am | by Bio-Medicine.Org | News | CommentsMarketsandMarkets: Global Minimally Invasive Surgery (MIS) Market Worth US$ 90.4 Billion by... -- DALLAS, Texas, September 16, 2010 /-
ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease
September 16, 2010 5:33 am | by Bio-Medicine.Org | News | CommentsIRVINE, Calif., Sept. 16 /- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced that it has initiated a Phase 3 clinical program of ISTA's proprietary formulation of REMURA™ (bromfenac ophthalmic solution for dry eye) for alleviating the signs and symptoms of dry eye...
PDL BioPharma Announces Retirement of $54.3 Million of 2.75% Convertible Notes Due 2023
September 16, 2010 5:33 am | by Bio-Medicine.Org | News | CommentsINCLINE VILLAGE, Nev., Sept. 16 /- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) announced today that it has completed the retirement of the remaining $54.3 million in aggregate principal of the Company's 2.75% Convertible Subordinated Notes, due August 16, 2023 (the "2023 Notes") in exchange...
Cornerstone OnDemand & #8217;s New Observation Checklist Offers Innovative Approach to Evaluating Real-Time Performance
September 16, 2010 5:32 am | by RealWire | News | CommentsCornerstone among the only talent management solutions to help organisations observe and measure employee competencies and performance on the fly and in the field London, September 16, 2010 - The ability to manage performance in industries such as healthcare, manufacturing and education...
Texting initiative expands to reinforce healthy teen behavior
September 16, 2010 5:32 am | by Baylor College of Medicine | News | CommentsTeens today communicate in a different way than in the past, and physicians and staff at the Baylor Teen Health Clinic are taking advantage of these new communication methods to reach their patients. "Teenagers are more attached to their phones than ever before but they are not...
